Apraclonidine

From Wikipedia, the free encyclopedia

Apraclonidine
Systematic (IUPAC) name
2,6-dichloro-N- (4,5-dihydro-1H-imidazol-2-yl) benzene-1,4-diamine
Identifiers
CAS number 66711-21-5
ATC code S01EA03
PubChem 2216
DrugBank APRD00012
Chemical data
Formula C9H10Cl2N4 
Mol. mass 245.108 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 98.7%
Metabolism  ?
Half life 8 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Apraclonidine is a sympathomimetic used in glaucoma therapy.

[edit] External links

  • Chen P, Chen J, Lu D, Chen Y, Hsiao C (2006). "Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients.". J Ocul Pharmacol Ther 22 (3): 182-7. PMID 16808679. 
  • Aslanides l, Tsiklis N, Ozkilic E, Coskunseven E, Pallikaris l, Jankov M (2006). "The effect of topical apraclonidine on subconjunctival hemorrhage and flap adherence in LASIK patients.". J Refract Surg 22 (6): 585-8. PMID 16805122. 
  • Koc F, Kansu T, Kavuncu S, Firat E (2006). "Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.". J Neuroophthalmol 26 (1): 25-9. PMID 16518162. 
  • Garibaldi D, Hindman H, Grant M, Iliff N, Merbs S. "Effect of 0.5% apraclonidine on ptosis in Horner syndrome.". Ophthal Plast Reconstr Surg 22 (1): 53-5. PMID 16418668. 
  • Onal S, Gozum N, Gucukoglu A. "Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.". Ophthalmic Surg Lasers Imaging 36 (6): 457-62. PMID 16355950.